Published in

Membrane Transporter Diseases, p. 349-364

DOI: 10.1007/978-1-4419-9023-5_23

Links

Tools

Export citation

Search in Google Scholar

Molecular genetics of transporters for norepinephrine, dopamine, and serotonin in behavioral traits and complex diseases

Journal article published in 2003 by Klaus Peter Lesch, Dennis L. Murphy
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Sodium/chloride-dependent neurotransmitter cotransporters, which constitute a gene superfamily (SLC6), are crucial for limiting neurotransmitter activity (Hertting and Axelrod 1961; Iversen 1971). At the plasma membrane, substrate influx is directly coupled to transmembrane ion gradients that provide the energy for transport against a concentration gradient. On the basis of their remarkable amino acid identity and their properties as targets of tri- and heterocyclic antidepressants, as well as of psychostimulants including amphetamine, cocaine, and their analogs, the carriers for the monoamines norepinephrine (NE), dopamine (DA), and serotonin (5-hydroxytryptamine, 5HT) comprise a distinct subfamily (Lesch et al. 1996; Amara and Sonders 1998).